Systematic Reviews
Copyright ©The Author(s) 2019.
World J Clin Pediatr. Jan 22, 2019; 8(1): 1-14
Published online Jan 22, 2019. doi: 10.5409/wjcp.v8.i1.1
Table 1 Characteristics of included studies: Evaluating vitamin D treatment in children with inflammatory bowel disease
StudyN1LocationDesignTreatment regimenVitamin D levels2
Treatment duration3Cumulative doseDisease activity4
BeforeAfter
Wingate, 201483 (CD)CanadaRCTA: 400 IU/d D3; B: 2000 IU/d D324 ± 7.9; A: 26 ± 9.2; B: 22 ± 6.8A: 28.8 ± 9.2 (3 mo), 28 ± 8.6 (6 mo); B: 34 ± 10 (3 mo), 34.4 ± 10.4 (6 mo)26 (183)A: 73200 IU; B: 366000 IUA: < 10:83 B: < 10:88
Pappa, 201271 (IBD)United StatesRCTA: 2000 IU/d D2; B: 2000 IU/d D3; C: 50000 IU/wk D2A: 16.1 ± 1; B: 14.7 ± 0.8; C: 51.3 ± 1A:25.7 ± 2.2 (6 wk); B:31.5 ± 1.9 (6 wk); C: 40.8 ± 2.6 (6 wk)6 (42)A: 84000 IU; B: 84000 IU; C: 300000 IUA: <10:54; B: <10:54; C: <10:78
Simek, 201632 (IBD)United StatesRCTA: 5000 IU/10 kg/wk D3; B: 1000 IU/10 kg/wk D3A: 24 ± 7; B: 23.7 ± 8.5A: 41.5 ± 9.6 (8 wk), 30.8 ± 4.2 (12 wk); B: 49.2 ± 13.6 (8 wk), 35.1 ± 8.4 (12 wk)6 (42)A: up to 150000 IU; B: up to 150000 IUUnknown
Shepherd, 201576 (IBD)AustraliaRetrospective< 3 yr: 200000 IU D3; 3-12 yr: 400000 IU D3; > 12 yr: 800000 IU D316.4 ± 3.258.4 ± 20.8 (1 mo); 34.8 ± 11.2 (3 mo); 27.6 ± 12.4 (6 mo)Single dose< 3 yr: 200000 IU D3; 3-12 yr: 400000 IU D3; > 12 yr: 800000 IU D310 (0-47.5) 0 mo; 2.5 (0-85) 6 mo
Santucci, 201461 (IBD)United StatesRetrospectiveA: no treatment; B: 400 IU/d; C: 600-1200 IU/d; D: 2000 IU/d or 50000 IU/wk45% < 30 ng/mL (baseline); 50% < 30 ng/mL; 25% < 30 ng/mL; 88% < 30 ng/mLUnknownUnknownUnknown